Sildenafil
Product Images NDC 53002-4719

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 53002-4719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530024719)

Packaging label for Sildenafil tablets, 20 mg strength, by RPK Pharmaceuticals, Inc. The label indicates a container with 30 tablets, marked as generic for Revatio 20 mg. It includes instructions to take as directed and mentions prescription use only. The label displays lot and expiration dates along with spaces for patient and prescriber information.*

FDA Label Image

Figure1 (Sildenafil Fig1)

A forest plot showing the change relative to Sildenafil alone for various interacting drugs, measuring AUC and Cmax values with 90% confidence intervals. The chart includes drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Ritonavir, and Saquinavir, and notes accompanying recommendations about dose adjustment or coadministration. Oral contraceptives data are also included.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A forest plot chart showing fold change and 95% confidence intervals for various pharmacokinetic parameters (AUC, Cmax, INR, AUC BT) of Sildenafil when co-administered with different interacting drugs. The chart includes dose adjustment recommendations such as 'No dose adjustment,' 'Coadministration not recommended,' and notes warnings for certain drug combinations.*

FDA Label Image

Figure3 (Sildenafil Fig3)

A line chart displaying change from baseline artery measurements over weeks 0, 4, and 12. The chart compares three groups: Sildenafil 40 mg TID, Sildenafil 80 mg TID, and a placebo, using different symbols and error bars to indicate variability.*

FDA Label Image

Figure4 (Sildenafil Fig4)

A chart comparing placebo and sildenafil 20 mg TID groups showing changes in 6-minute walk distance by various subgroups, including baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary artery pressure, and pulmonary vascular resistance. Data are presented with mean differences and confidence intervals for each category.*

FDA Label Image

Figure5 (Sildenafil Fig5)

A line graph comparing the percentage of patients with clinically erectile function over days from randomization, showing two curves labeled Placebo and Sildenafil. The x-axis represents the days from randomization, and the y-axis represents the percentage with clinically erectile function.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure of sildenafil showing its detailed molecular framework with labeled atoms and bonds including nitrogen, carbon, oxygen, sulfur, and hydrogen placements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.